投资者关系
Information disclosure Stock Information Presentation Materials and Newsletter Corporate Governance Investor Calendar Investor Enquiries
Future of TAVR for AR JenaValve TrilogyTM TAVR System
2021-01-07 16:14:20

全球领先“非醛交联”经导管主动脉干瓣系统1

上一篇：Introduction of TaurusWave® Lithotripsy Valvuloplasty System and FIM Clinical Trial
下一篇：2021 Business Update
Top